VERVE THERAPEUTICS INC's ticker is and the CUSIP is 92539P901. A total of 4 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33 | +266.7% | 2,500 | +400.0% | 0.00% | – |
| Q2 2023 | $9 | -10.0% | 500 | -28.6% | 0.00% | – |
| Q1 2023 | $10 | -97.1% | 700 | -96.0% | 0.00% | – |
| Q4 2022 | $342 | -99.9% | 17,700 | +9.3% | 0.00% | -100.0% |
| Q3 2022 | $556,000 | +768.8% | 16,200 | +285.7% | 0.00% | – |
| Q2 2022 | $64,000 | +611.1% | 4,200 | +950.0% | 0.00% | – |
| Q1 2022 | $9,000 | -69.0% | 400 | -50.0% | 0.00% | – |
| Q4 2021 | $29,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 25,000 | $360,500 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 700 | $10 | 0.00% |
| JANE STREET GROUP, LLC | 35,200 | $507,584 | 0.00% |